I
IMRX
Immuneering Corp
5.52
-0.14-2.47%After Hours: 5.52 0.00 0.00%18:05 04/10 EDT
OPEN/PREV CLOSE5.63/5.66
TODAY RANGE5.45-5.77
VOL573.72K
MARKET CAP356.88M
52 WEEK RANGE1.100-10.08
AVG VOL (3M)1.13M
% TURNOVER0.89%
TURNOVER--
P/E (TTM)-4.3362
% RANGE5.65%
EPS(TTM)-1.2730
P/E(FORWARD)-4.6780
P/B1.565
BVPS3.591
DIVIDEND--
P/S4,050.00
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP292.94M
SHARES OUTSTANDING64.65M
NEXT EARNINGS--
FREE FLOAT53.07M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·1d ago
Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings
Reuters·03/17 20:37
Immuneering to present atebimetinib ctDNA analysis at AACR Annual Meeting
TipRanks·03/16 10:20
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks·03/11 17:35
Mizuho Securities Sticks to Their Buy Rating for Immuneering (IMRX)
TipRanks·03/10 12:10
3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts
TipRanks·03/09 12:25
3 Best Stocks to Buy Today, 3/9/2026, According to Top Analysts
TipRanks·03/09 11:08
Immuneering (IMRX) Receives a Buy from Piper Sandler
TipRanks·03/09 10:56
Immuneering price target lowered to $12 from $13 at Piper Sandler
Dow Jones·03/09 10:01
Immuneering Price Target Maintained With a $11.00/Share by Needham
Benzinga·03/09 09:52
Needham Reiterates Buy on Immuneering, Maintains $11 Price Target